Carillon Tower Advisers’s NeoGenomics NEO Stock Holding History

Carillon Tower Advisers’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$63.2M	Sell	1,173,293 -80,054	-6%	-$3.62M	0.38%	80
2020 Q3	$46.2M	Sell	1,253,347 -275,421	-18%	-$10.2M	0.62%	22
2020 Q2	$47.4M	Sell	1,528,768 -273,883	-15%	-$7.59M	0.37%	90
2020 Q1	$47.4M	Hold	1,802,651	–	–	0.46%	59
2019 Q4	$52.7M	Sell	1,802,651 -200,000	-10%	-$4.76M	0.35%	88
2019 Q3	$38.3M	Hold	2,002,651	–	–	0.27%	135
2019 Q2	$43.9M	Hold	2,002,651	–	–	0.3%	116
2019 Q1	$41M	Hold	2,002,651	–	–	0.29%	127
2018 Q4	$25.3M	Hold	2,002,651	–	–	0.21%	184
2018 Q3	$30.7M	Buy	+2,002,651	New	+$27.7M	0.22%	174

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Carillon Tower Advisers's NEO Position: Q4 2020 in Review

Carillon Tower Advisers reduced its NeoGenomics (NEO) stake by 6.4% in Q4 2020, selling an estimated $3.62M and leaving 1,173,293 shares worth $63.2M. The position accounts for 0.38% of the portfolio, ranked #80.

Carillon Tower Advisers first reported a position in NEO in Q3 2018 and has held it in 10 quarters since. 340 funds tracked by Wall St. Rank hold NEO as of Q4 2020.

Carillon Tower Advisers held 1,173,293 shares of NeoGenomics worth $63.2M as of Q4 2020.
Carillon Tower Advisers sold 80,054 NeoGenomics shares in Q4 2020, an estimated $3.62M.
NeoGenomics made up 0.38% of Carillon Tower Advisers's portfolio in Q4 2020, its #80 holding.
Carillon Tower Advisers first reported a position in NeoGenomics in Q3 2018 and has held it in 10 quarters since.
340 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.